| Centennial Medical Group East, Llc | |
|
1937 W Harvard Ave Roseburg OR 97471-2720 | |
| (541) 677-7200 | |
| (541) 229-3309 |
| Full Name | Centennial Medical Group East, Llc |
|---|---|
| Speciality | Clinic/Center |
| Location | 1937 W Harvard Ave, Roseburg, Oregon |
| Authorized Official Name and Position | Kim Tyree (COO) |
| Authorized Official Contact | 5412293332 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Centennial Medical Group East, Llc 2570 Nw Edenbower Blvd Ste 100 Roseburg OR 97471-6214 Ph: (541) 677-7200 | Centennial Medical Group East, Llc 1937 W Harvard Ave Roseburg OR 97471-2720 Ph: (541) 677-7200 |
| NPI Number | 1235688805 |
|---|---|
| Provider Enumeration Date | 09/23/2016 |
| Last Update Date | 05/01/2020 |
| Medicare PECOS PAC ID | 9234397878 |
|---|---|
| Medicare Enrollment ID | O20170131002098 |
News Archive
Emerging Healthcare Solutions, Inc. announced today that it has closed its funding agreement with Celulas Genetica. EHSI will lock in up to 20% of earnings produced by Celulas Genetica when the agreement is funded in full.
An international multidisciplinary consortium, co-led by the European Organisation for Research and Treatment of Cancer (EORTC) and Boehringer Ingelheim (BI), has been convened to generate recommendations to standardize the use, analysis, and interpretation of patient-reported outcome (PRO) data in cancer clinical trials.
Triad Isotopes, Inc., a portfolio company of Parthenon Capital Partners, today announced that it has entered into an agreement to acquire the U.S. radiopharmacy network currently owned and operated by Covidien, a leading global healthcare products company based in Dublin, Ireland.
A new simple, inexpensive three-in-one test to diagnose a terrible trio of parasitic diseases that wreak havoc in the developing world is passing preliminary tests, scientists reported here today. Described during the 239th National Meeting of the American Chemical Society the test is for Chagas' disease, leishmaniasis, and "sleeping sickness" or African trypanosomiasis.
PuraMed BioScience, announced today that a clinical study of LipiGesic M has been completed. The study design was a double blind, placebo controlled, multi-site study measuring the effectiveness of LipiGesic™ M for the treatment of acute migraine attacks. The next steps include completion of the manuscript, submission for publication in a peer-reviewed medical journal and actual publication. In an effort to maximize the potential for publication, an embargo has been placed on the disclosure of any of the results of this study.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235688805 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD12182 (Oregon) | Secondary |
| 261QR1300X | Clinic/center - Rural Health | 38-3896 (Oregon) | Primary |
News Archive
Emerging Healthcare Solutions, Inc. announced today that it has closed its funding agreement with Celulas Genetica. EHSI will lock in up to 20% of earnings produced by Celulas Genetica when the agreement is funded in full.
An international multidisciplinary consortium, co-led by the European Organisation for Research and Treatment of Cancer (EORTC) and Boehringer Ingelheim (BI), has been convened to generate recommendations to standardize the use, analysis, and interpretation of patient-reported outcome (PRO) data in cancer clinical trials.
Triad Isotopes, Inc., a portfolio company of Parthenon Capital Partners, today announced that it has entered into an agreement to acquire the U.S. radiopharmacy network currently owned and operated by Covidien, a leading global healthcare products company based in Dublin, Ireland.
A new simple, inexpensive three-in-one test to diagnose a terrible trio of parasitic diseases that wreak havoc in the developing world is passing preliminary tests, scientists reported here today. Described during the 239th National Meeting of the American Chemical Society the test is for Chagas' disease, leishmaniasis, and "sleeping sickness" or African trypanosomiasis.
PuraMed BioScience, announced today that a clinical study of LipiGesic M has been completed. The study design was a double blind, placebo controlled, multi-site study measuring the effectiveness of LipiGesic™ M for the treatment of acute migraine attacks. The next steps include completion of the manuscript, submission for publication in a peer-reviewed medical journal and actual publication. In an effort to maximize the potential for publication, an embargo has been placed on the disclosure of any of the results of this study.
› Verified 6 days ago
A.k. Gombart M.d.p.c Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 532 W Umpqua St, Roseburg, OR 97470 Phone: 541-673-0133 | |
Roseburg Clinic Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2750 W Harvard Ave, Roseburg, OR 97471 Phone: 541-673-8988 Fax: 541-672-8103 | |
Douglas Medical Clinic Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1813 W Harvard Ave, Suite 201, Roseburg, OR 97470 Phone: 541-440-6390 Fax: 541-440-6392 | |
Laurence M Sharp Do Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1813 W Harvard Ave, Suite 426, Roseburg, OR 97471 Phone: 541-459-1611 Fax: 541-459-5741 | |
Bestmed Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1740 Nw Goetz Street, Roseburg, OR 97471 Phone: 541-672-4885 Fax: 541-672-4782 | |
Cow Creek Health & Wellness Ctr Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2589 Nw Edenbower Blvd, Roseburg, OR 97471 Phone: 541-672-8533 Fax: 855-670-1791 | |
Gordon F. Rose, Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 544 W Umpqua St Ste 104, Roseburg, OR 97470 Phone: 541-673-3334 Fax: 541-673-0814 |